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Background
Analysis of human monoclonal antibodies (mAbs) devel-
oped from HIV-1 infected donors have enormously con-
tributed to the identification of neutralization sensitive
epitopes on the HIV-1 envelope glycoprotein. We have
isolated 3 anti-V3 mAbs 277, 903 and 904 by hybridoma
technology from EBV transformed B cells of HIV-1 sero-
positive drug naive patients. The ELISA binding revealed a
subtype-C and subtype-A specific binding of antibody 277
and 903 while 904 exhibited cross reactivity also with
subtype-B V3. Epitope mapping of mAbs with overlapping
V3 peptides showed exclusive binding to V3 crown. The
antibodies displayed high and low neutralizing activity
against 2/5 tier 1 and 1/6 tier 2 viruses respectively.
Materials and methods
To identify binding specificities of mAb 904 within the V3
region specific to Indian clade C viruses, we designed syn-
thetic V3 mutant peptides (total of 23 peptides, 13 amino
acid long), by amino acid substitutions and determined the
binding reactivity by ELISA. Further, to assess the binding
efficiency of mAb 904 to the native viruses of different
clades, intact virion binding assays were performed.
Results
The binding of mAb 904 was substantially reduced
(% binding = 15.53) by substituting with arginine-311 in
place of glutamine (Q to R) (V3_3 peptide) in the crown
region of the V3C. In addition to the above (Q to R),
a second substitution of arginine-306 by aromatic amino
acid histidine (R to H) (V3_7 peptide), almost completely
abrogated the binding ability of mAb 904 with the peptide
(% binding = 3.77). This revealed that glutamine and argi-
nine at positions 311 and 306 respectively within the V3
region of envelope gp120 are crucial amino acids required
for binding of 904. Lower binding potential of mAb 904
with consensus V3B as compared to V3C (V3_1 peptide)
is corroborated by the low binding to V3_8 mutant
peptide (same amino acid sequence as that of con V3B)
(% binding = 3.55). Another residue required for binding
of mAb 904 to V3 was observed to be phenylalanine (F)
and when this was substituted by tryptophan (W) at
position 313 of the V3 peptide (V3_16), there was substan-
tial reduction (% binding = 15.27) in binding and when F
to W change was accompanied with a second substitution
of isoleucine (I) to methionine (M) at position 307 in the
V3 region (V3_18), the binding of 904 to this double
mutant peptide was further reduced by half (% binding
=8.11). A salient finding was that mAb 904 retained the
cross-reactive binding potential to V3 region of intact
viruses of different clades, suggesting that V3 epitopes
recognized by 904 are exposed on intact viruses.
Conclusions
Mapping revealed that mAb 904 tolerates most subtype
(C) specific changes and is a useful tool for identifying
clade C epitopes for immunogen design.
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